The Trump administration's freeze of over $2 billion in federal research grants to Harvard University has critically impacted its SMART IRB contract, which facilitates oversight for multiple-site medical research. The stop-work order arrived after Harvard rejected government demands affecting governance and institutional practices. This disruption threatens the process that ensures the protection and safety of patients participating in clinical studies, as oversight typically relies on funding for Institutional Review Board (IRB) processes that review, approve, and monitor compliance in research involving human subjects.
The freeze of federal research grants to Harvard disrupts critical oversight of medical studies, impacting the rights and safety of research participants.
Barbara Bierer highlights how the funding cuts hinder the protection and welfare of patients involved in research initiatives across multiple sites.
Collection
[
|
...
]